Literature DB >> 22527255

Utility of the inversion scout sequence (TI scout) in diagnosing myocardial amyloid infiltration.

Tarun Pandey1, Kedar Jambhekar, Raja Shaikh, Shelly Lensing, Sanjaya Viswamitra.   

Abstract

To evaluate the utility of inversion scout (TI-scout) obtained during cardiac magnetic resonance imaging (CMR) in diagnosing myocardial amyloid infiltration. A retrospective analysis of CMR exams in 39 patients (24 males, age range 29-77 years) was performed. Imaging was performed on a 1.5T system, and included steady state cine, post contrast TI-scout and delayed enhancement images. Evaluations included studies in 13 patients with myocardial amyloidosis and 26 patients without myocardial amyloidosis. To characterize abnormal nulling, the time to myocardial nulling on the TI scout was compared to the null times of the blood pool and spleen for each scan. The sensitivity and specificity of different tissue nulling abnormalities for myocardial amyloidosis were computed. The null times of tissues in 18/26 (69%) patients in the non-amyloid group followed a consistent order with the blood pool null time preceding the myocardial nulling which was equal to that of splenic nulling (Type 1 pattern). This order differed in all 13 patients with myocardial amyloidosis described as three non-mutually exclusive nulling categories: 10 patients had myocardial null time preceding or coincident with blood pool (Type 2 pattern); in 11 patients myocardial null time was non-coincident with splenic nulling (Type 3 pattern); and in 8 patients myocardial null time was non-coincident with both blood pool AND splenic nulling (Type 4 pattern). While no patient exhibited Type 4 nulling pattern in the non-amyloid group, 1/26 patient had a Type 2 and 7/26 patients had a Type 3 nulling pattern. A sensitivity of 100% was obtained when either Type 2 OR Type 3 nulling was present while a specificity of 100% was obtained when both Type 2 AND Type 3 nulling were present together (Type 4 pattern). Our study demonstrates that the pattern of nulling on the TI scout sequence CMR has potential diagnostic utility for the presence of myocardial amyloidosis. The temporal pattern of myocardial, blood pool and splenic nulling needs to be carefully evaluated on the TI scout sequence and could prove useful in other infiltrative cardiomyopathies.

Entities:  

Mesh:

Year:  2012        PMID: 22527255      PMCID: PMC3586540          DOI: 10.1007/s10554-012-0042-4

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  14 in total

Review 1.  The systemic amyloidoses: an overview.

Authors:  R H Falk; M Skinner
Journal:  Adv Intern Med       Date:  2000

2.  How we perform delayed enhancement imaging.

Authors:  Raymond J Kim; Dipan J Shah; Robert M Judd
Journal:  J Cardiovasc Magn Reson       Date:  2003-07       Impact factor: 5.364

3.  Assessment of restrictive cardiomyopathy of amyloid or idiopathic etiology by magnetic resonance imaging.

Authors:  F Celletti; R Fattori; G Napoli; O Leone; G Rocchi; L B Reggiani; G Gavelli
Journal:  Am J Cardiol       Date:  1999-03-01       Impact factor: 2.778

4.  MRI of acute myocarditis: a comprehensive approach based on various imaging sequences.

Authors:  Jean-Pierre Laissy; Benoît Messin; Olivier Varenne; Bernard Iung; Daniel Karila-Cohen; Elisabeth Schouman-Claeys; P Gabriel Steg
Journal:  Chest       Date:  2002-11       Impact factor: 9.410

5.  Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.

Authors:  M Yazaki; T Tokuda; A Nakamura; T Higashikata; J Koyama; K Higuchi; Y Harihara; S Baba; F Kametani; S Ikeda
Journal:  Biochem Biophys Res Commun       Date:  2000-08-11       Impact factor: 3.575

6.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

7.  Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.

Authors:  Imran S Syed; James F Glockner; Dali Feng; Philip A Araoz; Matthew W Martinez; William D Edwards; Morie A Gertz; Angela Dispenzieri; Jae K Oh; Diego Bellavia; A Jamil Tajik; Martha Grogan
Journal:  JACC Cardiovasc Imaging       Date:  2010-02

8.  Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study.

Authors:  Anja Wagner; Heiko Mahrholdt; Thomas A Holly; Michael D Elliott; Matthias Regenfus; Michele Parker; Francis J Klocke; Robert O Bonow; Raymond J Kim; Robert M Judd
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

9.  Noninvasive diagnosis of biopsy-proven cardiac amyloidosis.

Authors:  Joseph E Rahman; Emelie F Helou; Ramona Gelzer-Bell; Richard E Thompson; Chih Kuo; E Rene Rodriguez; Joshua M Hare; Kenneth L Baughman; Edward K Kasper
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

Review 10.  The role of endomyocardial biopsy in the diagnosis of cardiomyopathies.

Authors:  Andrea Frustaci; Maurizio Pieroni; Cristina Chimenti
Journal:  Ital Heart J       Date:  2002-06
View more
  11 in total

1.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Authors:  Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H Falk; Victor A Ferrari; Marianna Fontana; Olivier Gheysens; Julian D Gillmore; Andor W J M Glaudemans; Mazen A Hanna; Bouke P C Hazenberg; Arnt V Kristen; Raymond Y Kwong; Mathew S Maurer; Giampaolo Merlini; Edward J Miller; James C Moon; Venkatesh L Murthy; C Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Sanjiv J Shah; Riemer H J A Slart; Hein J Verberne; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-12       Impact factor: 5.952

2.  Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping.

Authors:  Bo Da Nam; Sung Mok Kim; Hye Na Jung; Yiseul Kim; Yeon Hyeon Choe
Journal:  Int J Cardiovasc Imaging       Date:  2018-05-30       Impact factor: 2.357

Review 3.  Cardiovascular imaging 2013 in the International Journal of Cardiovascular Imaging.

Authors:  Hiram G Bezerra; Ricardo A Costa; Johan H C Reiber; Frank J Rybicki; Paul Schoenhagen; Arthur A Stillman; Johan De Sutter; Nico R L Van de Veire
Journal:  Int J Cardiovasc Imaging       Date:  2014-04       Impact factor: 2.357

Review 4.  Clinical use of cardiac PET/MRI: current state-of-the-art and potential future applications.

Authors:  Patrick Krumm; Stefanie Mangold; Sergios Gatidis; Konstantin Nikolaou; Felix Nensa; Fabian Bamberg; Christian la Fougère
Journal:  Jpn J Radiol       Date:  2018-03-10       Impact factor: 2.374

5.  Cardiovascular magnetic resonance patterns of biopsy proven cardiac involvement in systemic sclerosis.

Authors:  Patrick Krumm; Karin A L Mueller; Karin Klingel; Ulrich Kramer; Marius S Horger; Tanja Zitzelsberger; Reinhard Kandolf; Meinrad Gawaz; Konstantin Nikolaou; Bernhard D Klumpp; Joerg C Henes
Journal:  J Cardiovasc Magn Reson       Date:  2016-10-21       Impact factor: 5.364

6.  Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance.

Authors:  Nicola Martini; Alberto Aimo; Andrea Barison; Daniele Della Latta; Giuseppe Vergaro; Giovanni Donato Aquaro; Andrea Ripoli; Michele Emdin; Dante Chiappino
Journal:  J Cardiovasc Magn Reson       Date:  2020-12-07       Impact factor: 5.364

7.  Usefulness of TI-scout images in the assessment of late gadolinium enhancement in children.

Authors:  Badr Bannan; Julien Aguet; Aswathy Vaikom House; Navjot Gill; Vivian P Tassos; Afsaneh Amirabadi; Mike Seed; Christopher Z Lam; Shi-Joon Yoo
Journal:  J Cardiovasc Magn Reson       Date:  2021-03-18       Impact factor: 5.364

8.  The Auxiliary Role of Cardiac Magnetic Resonance Feature-Tracking Parameters in the Differentiation between Cardiac Amyloidosis and Constrictive Pericarditis.

Authors:  Sanaz Asadian; Mahta Farzin; Faezeh Tabesh; Nahid Rezaeian; Hooman Bakhshandeh; Leila Hosseini; Yaser Toloueitabar; Mohammad Mehdi Hemmati Komasi
Journal:  Cardiol Res Pract       Date:  2021-10-23       Impact factor: 1.866

Review 9.  Multimodality Imaging in the Evaluation and Management of Cardiac Amyloidosis.

Authors:  Yiu Ming Khor; Sarah Cuddy; Rodney H Falk; Sharmila Dorbala
Journal:  Semin Nucl Med       Date:  2020-02-09       Impact factor: 4.802

10.  Myocardial nulling pattern in cardiac amyloidosis on time of inversion scout magnetic resonance imaging sequence - A new observation of temporal variability.

Authors:  Harshavardhan Mahalingam; Binita Riya Chacko; Aparna Irodi; Elizabeth Joseph; Leena R Vimala; Viji Samuel Thomson
Journal:  Indian J Radiol Imaging       Date:  2018 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.